iFIELD

iFIELD proposes a new approach to cancer treatment that provides convenience and safer effects for cancer patients while addressing the complexities and severe side effects associated with current cancer treatment approaches. iFIELD delivers alternating current electric fields at specific frequencies tailored to individual cancer patients, effectively suppressing cancer cells while causing minimal harm to normal cells. This ground-breaking treatment has several advantages: firstly, combining the iFIELD treatment with traditional anticancer therapies improves survival significantly; in the case of terminal pancreatic cancer patients, the combined approach demonstrates 10% or more enhancement in the effects of cancer treatment when compared to anticancer treatment alone. Secondly, the iFIELD treatment is applicable to different types of cancers, and when combined with chemotherapy, the treatment outperforms chemotherapy alone by 1.5 to 2 times in terms of therapeutic efficacy. iFIELD treatment provides patients with a more comfortable and effective alternative to traditional cancer treatments, aiming to improve their overall well-being by reducing the stress and financial burden associated with risky surgical procedures or chemotherapy. In addition to improved efficacy, test results show that combining electric field therapy with traditional chemotherapy minimises side effects in several of ways. Blood-related indicators show higher survival rates for white blood cells and platelets during electric field treatment; symptoms such as abdominal pain, diarrhoea, and vomiting are significantly reduced in the gastrointestinal system. This innovative method enables patients can receive treatment for up to three hours per day and then resume their daily activities without significant disruption to their routines. Red Dot Award: Design Concept | Concept | Life Science